Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03700970 · ClinicalTrials.gov registry record · Phase 4

Comparing Local Anesthetics for TAP Block During Abdominally-based Free Flap for Breast Reconstruction

A Phase 4 study of Anesthesia and Breast Reconstruction, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
Phase 4
Development phase
60
Enrollment target
1
Study location

NCT03700970 is a Phase 4 study of Anesthesia and Breast Reconstruction that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03700970, a Phase 4 study of Anesthesia and Breast Reconstruction, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will compare the efficiency of transversus abominus plane (TAP) block using liposomal bupivacaine versus plain bupivacaine that is administered in the operating room under ultrasound guidance prior to the in patients undergoing abdominally-based free flap breast reconstruction at Vanderbilt University Medical Center.

Interventions

  • DRUG Liposomal bupivacaine
  • DRUG Regular bupivacaine

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2019-06-13
Est. Completion 2021-03-30
Phase Phase 4

What the Registry Record Tells You About NCT03700970

The ClinicalTrials.gov registry entry for NCT03700970 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,409-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Liposomal bupivacaine is the first listed.

NCT03700970 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT03700970 about?

NCT03700970 is a clinical study titled "Comparing Local Anesthetics for TAP Block During Abdominally-based Free Flap for Breast Reconstruction". This study will compare the efficiency of transversus abominus plane (TAP) block using liposomal bupivacaine versus plain bupivacaine that is administered in the operating room under ultrasound guidance prior to the in patients undergoing abdominally-based free flap breast reconstruction at Vanderbi...

What is the current status of trial NCT03700970?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2019-06-13. Estimated completion is 2021-03-30.

What conditions does trial NCT03700970 study?

This clinical trial studies the following conditions: Anesthesia, Breast Reconstruction, Transverse Abdominis Plane Block.

What interventions are being tested in trial NCT03700970?

The interventions under investigation include: Liposomal bupivacaine (DRUG), Regular bupivacaine (DRUG).

Who is sponsoring clinical trial NCT03700970?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03700970 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.